Levetiracetam Actavis

देश: न्यूज़ीलैंड

भाषा: अंग्रेज़ी

स्रोत: Medsafe (Medicines Safety Authority)

सक्रिय संघटक:

Levetiracetam 500mg;  

थमां उपलब्ध:

Teva Pharma (New Zealand) Limited

INN (इंटरनेशनल नाम):

Levetiracetam 500 mg

डोज़:

500 mg

फार्मास्यूटिकल फॉर्म:

Film coated tablet

रचना:

Active: Levetiracetam 500mg   Excipient: Colloidal silicon dioxide Crospovidone Magnesium stearate Opadry yellow 85F32371 Povidone

प्रिस्क्रिप्शन प्रकार:

Prescription

द्वारा बनाया गया:

Neuland Laboratories Limited

चिकित्सीय संकेत:

Use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation. Monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy. Add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy (JME). Add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy (IGE).

उत्पाद समीक्षा:

Package - Contents - Shelf Life: Blister pack, PVC/Al - 60 tablets - 36 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE with LDPE screw cap and tamper evident - 100 tablets - 36 months from date of manufacture stored at or below 25°C

प्राधिकरण की तारीख:

2015-01-22